The beginning of ending hepatitis C virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

Eui Cheol Shin, Ji Won Han, Wonseok Kang, Takanobu Kato, Seong Jun Kim, Jin Zhong, Seungtaek Kim, Su Hyung Park, Pil Soo Sung, Koichi Watashi, Jun Yong Park, Marc P. Windisch, Jong Won Oh, Takaji Wakita, Kwang Hyub Han, Sung Key Jang

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV‐related liver cirrhosis and hepatocellular carcinoma. The use of direct‐acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5–8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.

Original languageEnglish
Article number302
JournalViruses
Volume12
Issue number3
DOIs
Publication statusPublished - 2020

All Science Journal Classification (ASJC) codes

  • Infectious Diseases
  • Virology

Fingerprint Dive into the research topics of 'The beginning of ending hepatitis C virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses'. Together they form a unique fingerprint.

  • Cite this

    Shin, E. C., Han, J. W., Kang, W., Kato, T., Kim, S. J., Zhong, J., Kim, S., Park, S. H., Sung, P. S., Watashi, K., Park, J. Y., Windisch, M. P., Oh, J. W., Wakita, T., Han, K. H., & Jang, S. K. (2020). The beginning of ending hepatitis C virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses. Viruses, 12(3), [302]. https://doi.org/10.3390/v12030302